Houston Fibroids

Name

Houston Fibroids

Legal name

Texas Endovascular

Website

https://houstonfibroids.com

Company type

Private

Founded year

2015

Operating status

Operating

Headcount range

11–50 employees

Ownership category

akta.pro rank

Product category

Interventional Radiology & Women's Health Services

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Health Services (8000)

akta.pro primary industry

Interventional Radiology & Image-Guided Therapy Systems (HLAHABAG)

Keywords

• Uterine fibroid treatment
• Uterine fibroid embolization
• Interventional radiology services
• Minimally invasive procedures
• Women's vascular healthcare

Headquarters

HQ city

Bellaire

HQ country

United States

HQ region

North America

Offices5 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Infrastructure, Technology or R&D

Revenue model

1. Medical Procedure Revenue: Houston Fibroids generates revenue through providing UFE procedures and related medical services. The practice accepts most major insurance plans including Medicare, Blue Cross Blue Shield, Aetna, Cigna, UnitedHealthcare, Humana, and TMHP. Most patients pay little to nothing out of pocket due to insurance coverage.

Pricing tiers

Go-to-market motion1 record

Distribution channels2 records

Marketing channels4 records

Core offering

Houston Fibroids is a specialized treatment center operating under Texas Endovascular that delivers Uterine Fibroid Embolization (UFE), a minimally invasive, image-guided, catheter-based procedure performed by board-certified interventional radiologists to block blood flow to fibroids and shrink them. Services are provided as outpatient same-day procedures across five clinics in Greater Houston, with insurance coverage verification done prior to treatment.

Product overview

Houston Fibroids is a specialized fibroid treatment practice offering Uterine Fibroid Embolization (UFE) as its primary service. UFE is a minimally invasive, image-guided procedure performed by board-certified interventional radiologists that shrinks fibroids by blocking their blood supply. The treatment is performed as an outpatient same-day procedure with a pinhole incision, preserving the uterus without requiring hysterectomy. The practice reports >90% symptom relief rate and has performed 40,000+ procedures.

Differentiator

Problem solved

Functional benefit

Brands

• Texas Hemorrhoid Institute: Sister site specializing in hemorrhoid artery embolization (HAE)
• Texas Prostate Institute
• Texas Knee Institute
• Dallas Fibroid Center

Products and services

• Uterine Fibroid Embolization (UFE) A minimally invasive, image-guided procedure where an interventional radiologist guides a catheter through a pinhole incision in the wrist or groin to the uterine arteries and releases microscopic particles to block blood flow to fibroids, causing them to shrink and symptoms to fade. It is performed as an outpatient same-day procedure under moderate sedation and treats all fibroids at once while preserving the uterus with 1-2 weeks of recovery.

Quantifiable outcome

• 90% symptom relief rate for UFE patients
• +3 more outcomes

Named customers4 records

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• The Fibroid Treatment Center: Specialty outpatient centers offering UFE and other non-surgical fibroid treatments; directly comparable in clinical offering and direct-to-patient education model targeting women seeking alternatives to hysterectomy.
• USA Fibroid Centers: National network of outpatient fibroid treatment centers specializing in UFE; competes directly with Houston Fibroids in the same product category (non-surgical fibroid treatment) using a similar DTC marketing and physician-staffed clinic model.
• Fibroid Institute of Texas: Texas-based fibroid treatment practice offering UFE and related procedures; geographically overlapping competitor within the same state market with comparable clinical approach.
• VIVA EVE: New York-based fibroid treatment center offering UFE and other minimally invasive fibroid treatments; comparable outpatient specialty practice positioning around women's reproductive health.
• Atlanta Fibroid Center: Regional specialty clinic dedicated to UFE in the Atlanta metro; offers a similar interventional radiology-based, DTC-focused fibroid treatment model to Houston Fibroids.

Broad incumbents

• Radiology Partners: Largest US radiology physician practice whose interventional radiologists perform UFE and other image-guided procedures; competes for the same referring physicians and patients in the outpatient IR service category.
• HCA Healthcare: Large national hospital system whose facilities include interventional radiologists performing UFE; competes in the same clinical service line but as part of a much broader service portfolio rather than as a UFE specialist.
• Tenet Healthcare: Multi-state hospital and ambulatory operator with interventional radiology capability offering UFE within women's health service lines; competes broadly for fibroid patients without a specialty-focused niche.

Emerging players

• Pelvic Health Centers: Emerging outpatient women's health practice with overlap in non-surgical treatment of pelvic conditions including fibroids; partial overlap in target patient and minimally invasive treatment philosophy.

Others

• Dallas Fibroid Center: Wholly-owned brand under Texas Endovascular (the parent of Houston Fibroids); operates as an integrated peer offering UFE in the Dallas market rather than a true external competitor.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xx.com/fibroidshouston
• Facebookfacebook.com/HoustonFibroids
• LinkedInlinkedin.com/company/houstonfibroids

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Houston Fibroids